STOCK TITAN

[Form 4] Microvision Inc Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

MicroVision director Simon Biddiscombe received 22,007 shares of common stock on 09/02/2025 when restricted stock units (RSUs) vested and converted to shares on a unit-for-unit basis with no payment required. After the distribution, the reporting person beneficially owned 247,285 shares. The filing corrects an earlier Form 4 that misstated the total RSUs granted in June 2025; the correct grant amount was 88,028 RSUs, and the vesting here reflects that corrected figure. The transaction was reported by an attorney-in-fact on 09/03/2025.

Il direttore di MicroVision, Simon Biddiscombe, ha ricevuto 22.007 azioni ordinarie il 02/09/2025 quando le unità di azioni vincolate (RSU) sono maturate e si sono convertite in azioni con rapporto unità per unità senza alcun pagamento richiesto. Dopo la distribuzione, la persona segnalante deteneva beneficiariamente 247.285 azioni. La comunicazione rettifica un precedente Modulo 4 che aveva indicato in modo errato il totale delle RSU concesse a giugno 2025; l'ammontare corretto della concessione era di 88.028 RSU, e la maturazione qui riportata riflette tale cifra corretta. La transazione è stata segnalata da un procuratore il 03/09/2025.

El director de MicroVision, Simon Biddiscombe, recibió 22.007 acciones ordinarias el 02/09/2025 cuando las unidades de acciones restringidas (RSU) vencieron y se convirtieron en acciones a razón de una unidad por una sin pago alguno. Tras la distribución, la persona informante poseía beneficiariamente 247.285 acciones. La presentación corrige un Formulario 4 anterior que declaró erróneamente el total de RSU otorgadas en junio de 2025; la cantidad correcta fue de 88.028 RSU, y la consolidación aquí reflejada corresponde a esa cifra corregida. La transacción fue reportada por un apoderado el 03/09/2025.

MicroVision 이사 사이먼 비디스콤(Simon Biddiscombe)은 2025-09-02에 보통주 22,007주를 수령했습니다. 제한주식단위(RSU)가 성취되어 1대1 비율로 주식으로 전환되었으며 별도의 대금은 요구되지 않았습니다. 배포 후 보고자는 247,285주를 실질적으로 보유하게 되었습니다. 이번 제출은 2025년 6월에 부여된 RSU 총액을 잘못 기재한 이전의 Form 4를 정정한 것으로, 정확한 부여 수량은 88,028 RSU이며 여기서의 성취는 해당 정정된 수치를 반영합니다. 이 거래는 2025-09-03에 대리인이 신고했습니다.

Le directeur de MicroVision, Simon Biddiscombe, a reçu 22 007 actions ordinaires le 02/09/2025 lorsque des unités d'actions restreintes (RSU) ont vesté et été converties en actions à raison d'une unité pour une, sans paiement requis. Après la distribution, la personne déclarante détenait bénévolement 247 285 actions. Le dépôt corrige un formulaire 4 antérieur qui avait indiqué de manière erronée le nombre total de RSU accordées en juin 2025 ; le montant correct de la subvention était de 88 028 RSU, et le vesting ici reflète ce chiffre corrigé. La transaction a été déclarée par un mandataire le 03/09/2025.

MicroVision-Direktor Simon Biddiscombe erhielt am 02.09.2025 22.007 Stammaktien, als Restricted Stock Units (RSUs) fällig wurden und ohne Zahlungspflicht eins zu eins in Aktien umgewandelt wurden. Nach der Zuteilung hielt die meldende Person wirtschaftlich 247.285 Aktien. Die Meldung korrigiert ein früheres Formular 4, das die im Juni 2025 gewährten RSUs fehlerhaft angegeben hatte; die korrekte Zuteilungsanzahl betrug 88.028 RSUs, und die hier dargestellte Vesting-Transaktion entspricht dieser korrigierten Zahl. Die Transaktion wurde am 03.09.2025 von einem Bevollmächtigten gemeldet.

Positive
  • 22,007 shares received via vested RSUs converted on a unit-for-unit basis, increasing director alignment with shareholders
  • Correction made to prior Form 4 to reflect the accurate RSU grant amount, improving disclosure accuracy
Negative
  • Prior Form 4 misreported RSU grant amount, indicating an administrative reporting error that required amendment

Insights

TL;DR: Director received vested RSUs that converted to 22,007 shares, increasing reported ownership to 247,285 shares; filing corrects a prior reporting error.

The distribution of vested RSUs at no cost increases the director's direct equity stake and aligns compensation realization with service-based vesting conditions. The correction of the prior Form 4 grant amount is an important disclosure housekeeping item: it ensures the company's insider ownership records are accurate. This filing does not show open-market purchases or sales and contains no derivative activity retained after vesting. Impact on outstanding share counts or control appears immaterial based on the data provided.

TL;DR: Vesting and conversion of RSUs to shares is routine director compensation; amended disclosure fixes an earlier administrative error.

Vesting conditions tied to continued service are typical for board compensation. The note correcting the June 2025 RSU grant quantity improves transparency and reduces risk of future compliance questions. There is no indication of accelerated vesting for cause, no sales, and no change in governance status. The filing appears procedural and contains no material governance red flags beyond the corrected prior report.

Il direttore di MicroVision, Simon Biddiscombe, ha ricevuto 22.007 azioni ordinarie il 02/09/2025 quando le unità di azioni vincolate (RSU) sono maturate e si sono convertite in azioni con rapporto unità per unità senza alcun pagamento richiesto. Dopo la distribuzione, la persona segnalante deteneva beneficiariamente 247.285 azioni. La comunicazione rettifica un precedente Modulo 4 che aveva indicato in modo errato il totale delle RSU concesse a giugno 2025; l'ammontare corretto della concessione era di 88.028 RSU, e la maturazione qui riportata riflette tale cifra corretta. La transazione è stata segnalata da un procuratore il 03/09/2025.

El director de MicroVision, Simon Biddiscombe, recibió 22.007 acciones ordinarias el 02/09/2025 cuando las unidades de acciones restringidas (RSU) vencieron y se convirtieron en acciones a razón de una unidad por una sin pago alguno. Tras la distribución, la persona informante poseía beneficiariamente 247.285 acciones. La presentación corrige un Formulario 4 anterior que declaró erróneamente el total de RSU otorgadas en junio de 2025; la cantidad correcta fue de 88.028 RSU, y la consolidación aquí reflejada corresponde a esa cifra corregida. La transacción fue reportada por un apoderado el 03/09/2025.

MicroVision 이사 사이먼 비디스콤(Simon Biddiscombe)은 2025-09-02에 보통주 22,007주를 수령했습니다. 제한주식단위(RSU)가 성취되어 1대1 비율로 주식으로 전환되었으며 별도의 대금은 요구되지 않았습니다. 배포 후 보고자는 247,285주를 실질적으로 보유하게 되었습니다. 이번 제출은 2025년 6월에 부여된 RSU 총액을 잘못 기재한 이전의 Form 4를 정정한 것으로, 정확한 부여 수량은 88,028 RSU이며 여기서의 성취는 해당 정정된 수치를 반영합니다. 이 거래는 2025-09-03에 대리인이 신고했습니다.

Le directeur de MicroVision, Simon Biddiscombe, a reçu 22 007 actions ordinaires le 02/09/2025 lorsque des unités d'actions restreintes (RSU) ont vesté et été converties en actions à raison d'une unité pour une, sans paiement requis. Après la distribution, la personne déclarante détenait bénévolement 247 285 actions. Le dépôt corrige un formulaire 4 antérieur qui avait indiqué de manière erronée le nombre total de RSU accordées en juin 2025 ; le montant correct de la subvention était de 88 028 RSU, et le vesting ici reflète ce chiffre corrigé. La transaction a été déclarée par un mandataire le 03/09/2025.

MicroVision-Direktor Simon Biddiscombe erhielt am 02.09.2025 22.007 Stammaktien, als Restricted Stock Units (RSUs) fällig wurden und ohne Zahlungspflicht eins zu eins in Aktien umgewandelt wurden. Nach der Zuteilung hielt die meldende Person wirtschaftlich 247.285 Aktien. Die Meldung korrigiert ein früheres Formular 4, das die im Juni 2025 gewährten RSUs fehlerhaft angegeben hatte; die korrekte Zuteilungsanzahl betrug 88.028 RSUs, und die hier dargestellte Vesting-Transaktion entspricht dieser korrigierten Zahl. Die Transaktion wurde am 03.09.2025 von einem Bevollmächtigten gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BIDDISCOMBE SIMON

(Last) (First) (Middle)
18390 NE 68TH STREET

(Street)
REDMOND WA 98052

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 M 22,007 A $0.00(1) 247,285 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0.00(2) 09/02/2025 M 22,007 09/02/2025(3) 09/02/2025(3) Common Stock 22,007 $0.00 0 D
Explanation of Responses:
1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.
2. At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.
3. RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.
/s/ Drew G. Markham, attorney-in-fact for Simon Biddiscombe 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did MicroVision (MVIS) report for Simon Biddiscombe?

Simon Biddiscombe received 22,007 shares on 09/02/2025 when vested RSUs converted to common stock at no cost.

How many shares does Simon Biddiscombe beneficially own after the transaction?

247,285 shares beneficially owned following the reported distribution.

Why was an amended disclosure included in the Form 4?

The June 2025 RSU grant was previously misstated on a Form 4; the correct grant amount is 88,028 RSUs and the vesting here reflects that corrected figure.

Were any shares sold or purchased on the open market in this filing?

No. The filing reports vested RSUs converting to shares (code M) with a $0.00 price; there are no market purchases or dispositions reported.

Do the vested RSUs have any payment requirement?

No payment was required. RSUs converted to common stock on a unit-for-unit basis without payment.
Microvision

NASDAQ:MVIS

MVIS Rankings

MVIS Latest News

MVIS Latest SEC Filings

MVIS Stock Data

331.06M
297.23M
1.24%
28.28%
18.91%
Scientific & Technical Instruments
Electronic Components, Nec
Link
United States
REDMOND